Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Bladder Dysfunction Reports
Erschienen in: Current Bladder Dysfunction Reports 2/2017

27.04.2017 | Cancer-Associated Voiding Dysfunction (A Peterson, Section Editor)

The Male Transobturator Sling for Stress Incontinence After the Treatment of Prostate Cancer

verfasst von: James Mason, Bradley Erickson

Erschienen in: Current Bladder Dysfunction Reports | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The purpose of this review is to describe the use of male transobturator slings for the treatment of post-prostatectomy urinary incontinence. We aim to cover available slings on the market and give some background history of transobturator sling development.

Recent Findings

Although there has been a paucity of new transobturator slings released on the market over the last 5 years, there has emerged new data on product variations of the transobturator sling, including the Argus T adjustable sling, the Virtue Quadratic sling, the ATOMS sling, and the AdVance XP sling. Evidence that radiotherapy worsens outcomes, urodynamic studies may play some role in patient selection with Valsalva leak point pressure (VLPP) <100 cm H20 showing improved success, and salvage of sling failures are more optimal with artificial urinary sphincter (AUS) as compared to repeat sling placement, highlights the recent technical findings for the use of transobturator male urethral slings for the treatment of post-prostatectomy urinary incontinence.

Summary

Male transobturator slings and its variations are efficacious in the treatment of post-prostatectomy urinary incontinence given proper patient selection and appropriate device implantation practices. Patients with mild to moderate stress urinary incontinence that have had no prior radiotherapy and have some ability to coapt the external urethral sphincter have the highest success rates.
Literatur
1.
Control CD. Prevention. CDC/NCHS National Hospital Discharge Survey, 2010. Atlanta: CDC; 2010.
2.
3.
Herr HW. Quality of life of incontinent men after radical prostatectomy. J Urol. 1994;151(3):652–4.PubMed
4.
Scott F, Bradley W, Timm G. Treatment of urinary incontinence by an implantable prosthetic urinary sphincter. J Urol. 1974;112(1):75–80.PubMed
5.
Van der Aa F, Drake MJ, Kasyan GR, Petrolekas A, Cornu JN. Young academic urologists functional Urology G. The artificial urinary sphincter after a quarter of a century: a critical systematic review of its use in male non-neurogenic incontinence. Eur Urol. 2013;63(4):681–9. doi:10.​1016/​j.​eururo.​2012.​11.​034.CrossRefPubMed
6.
7.
Brant WO, Erickson BA, Elliott SP, Powell C, Alsikafi N, McClung C, et al. Risk factors for erosion of artificial urinary sphincters: a multicenter prospective study. Urology. 2014;84(4):934–9.CrossRefPubMedPubMedCentral
8.
Berry J. A new procedure for correction of urinary incontinence-preliminary report. J Urol. 1961;85(5):771.
9.
Kaufman J. Urethral compression operations for the treatment of post-prostatectomy incontinence. J Urol. 1973;110(1):93.PubMed
10.
Kishev SV. Suprapubic wad suspension combined perineal-abdominal approach for correction of postprostatectomy urinary incontinence. Urology. 1978;11(1):28–32.CrossRefPubMed
11.
Schaeffer AJ, Clemens JQ, Ferrari M, Stamey TA. The male bulbourethral sling procedure for post-radical prostatectomy incontinence. J Urol. 1998;159(5):1510–5.CrossRefPubMed
12.
Comiter CV. The male perineal sling: intermediate-term results. Neurourol Urodyn. 2005;24(7):648–53.CrossRefPubMed
13.
Guimarães M, Oliveira R, Pinto R, Soares A, Maia E, Botelho F, et al. Intermediate-term results, up to 4 years, of a bone-anchored male perineal sling for treating male stress urinary incontinence after prostate surgery. BJU Int. 2009;103(4):500–4.CrossRefPubMed
14.
Giberti C, Gallo F, Schenone M, Cortese P. The bone-anchor sub-urethral sling for the treatment of iatrogenic male incontinence: subjective and objective assessment after 41 months of mean follow-up. World J Urol. 2008;26(2):173–8.CrossRefPubMed
15.
Styn NR, McGuire EJ, Latini JM. Bone-anchored sling for male stress urinary incontinence: assessment of complications. Urology. 2011;77(2):469–73.CrossRefPubMed
16.
De Ridder D, Rehder P. The AdVance® male sling: anatomic features in relation to mode of action. Eur Urol Suppl. 2011;10(4):383–9.CrossRef
17.
Bauer RM, Mayer ME, Gratzke C, Soljanik I, Buchner A, Bastian PJ, et al. Prospective evaluation of the functional sling suspension for male postprostatectomy stress urinary incontinence: results after 1 year. Eur Urol. 2009;56(6):928–33.CrossRefPubMed
18.
Ajay D, Zhang H, Gupta S, Selph JP, Belsante MJ, Lentz AC, et al. The artificial urinary sphincter is superior to a secondary transobturator male sling in cases of a primary sling failure. J Urol. 2015;194(4):1038–42.CrossRefPubMed
19.
Rehder P, Gozzi C. Transobturator sling suspension for male urinary incontinence including post-radical prostatectomy. Eur Urol. 2007;52(3):860–7.CrossRefPubMed
20.
McCammon K, Haab F. AdVance® male sling: surgical technique and postoperative patient management. Eur Urol Suppl. 2011;10(4):395–400.CrossRef
21.
Welk BK, Herschorn S. The male sling for post-prostatectomy urinary incontinence: a review of contemporary sling designs and outcomes. BJU Int. 2012;109(3):328–44.CrossRefPubMed
22.
Zuckerman JM, Edwards B, Henderson K, Beydoun HA, McCammon KA. Extended outcomes in the treatment of male stress urinary incontinence with a transobturator sling. Urology. 2014;83(4):939–45.CrossRefPubMed
23.
Kowalik CG, DeLong JM, Mourtzinos AP. The advance transobturator male sling for post-prostatectomy incontinence: subjective and objective outcomes with 3 years follow up. Neurourol Urodyn. 2015;34(3):251–4.CrossRefPubMed
24.
• Suskind AM, Bernstein B, Murphy-Setzko M. Patient-perceived outcomes of the AdVance sling up to 40 months post procedure. Neurourol Urodyn. 2011;30(7):1267–70. A non-randomized prospective review of patients who underwent either an adjustable Argus sling(retropubic) or non-adjustable Advance sling. There was no significant difference in overall outcomes, including objective outcomes, continence and patient satisfaction. Argus recipients did require revisions for sling tensioning in 6 of 25 patientsPubMed
25.
Gill BC, Swartz MA, Klein JB, Rackley RR, Montague DK, Vasavada SP, et al. Patient perceived effectiveness of a new male sling as treatment for post-prostatectomy incontinence. J Urol. 2010;183(1):247–52.CrossRefPubMed
26.
Chung E, Smith P, Malone G, Cartmill R. Adjustable versus non-adjustable male sling for post-prostatectomy urinary incontinence: a prospective clinical trial comparing patient choice, clinical outcomes and satisfaction rate with a minimum follow up of 24 months. Neurourol Urodyn. 2015.
27.
Rehder P, Haab F, Cornu J-N, Gozzi C, Bauer RM. Treatment of postprostatectomy male urinary incontinence with the transobturator retroluminal repositioning sling suspension: 3-year follow-up. Eur Urol. 2012;62(1):140–5.CrossRefPubMed
28.
Bauer RM, Mayer ME, May F, Gratzke C, Buchner A, Soljanik I, et al. Complications of the AdVance transobturator male sling in the treatment of male stress urinary incontinence. Urology. 2010;75(6):1494–8.CrossRefPubMed
29.
Rehder P. Freiin vGG, Pichler R, Glodny B. The treatment of postprostatectomy incontinence with the retroluminal transobturator repositioning sling (advance): lessons learnt from accumulative experience. Archivos espanoles de urologia. 2009;62(10):860–70.PubMed
30.
Hübner WA, Gallistl H, Rutkowski M, Huber ER. Adjustable bulbourethral male sling: experience after 101 cases of moderate-to-severe male stress urinary incontinence. BJU Int. 2011;107(5):777–82.CrossRefPubMed
31.
Romano SV, Metrebian SE, Vaz F, Muller V, D'Ancona C, de Souza E, et al. Long-term results of a phase III multicentre trial of the adjustable male sling for treating urinary incontinence after prostatectomy: minimum 3 years. Actas urologicas espanolas. 2009;33(3):309–14.CrossRefPubMed
32.
•• Bochove-Overgaauw DM, Schrier BP. An adjustable sling for the treatment of all degrees of male stress urinary incontinence: retrospective evaluation of efficacy and complications after a minimal followup of 14 months. J Urol. 2011;185(4):1363–8. A small randomized comparison of patients receiving either an adjustable Argus T (transobturator) or non-adjustable Advance sling. There Argus T group had significantly lower 24hr pad weights but no difference in the number of pad changes over 24hrs. The number of patients cured were similar, but overall patient satisfaction rates were higher in the Argus T group based on the administered QOL questionnaire. Interestingly patient objective and subjective outcomes did not correlate well and the authors called for wider evaluation parameters post operatively to truly evaluate the benefits of sling placement CrossRefPubMed
33.
Bauer RM, Rutkowski M, Kretschmer A, Casuscelli J, Stief CG, Huebner W. Efficacy and complications of the adjustable sling system ArgusT for male incontinence: results of a prospective 2-center study. Urology. 2015;85(2):316–20.CrossRefPubMed
34.
Lima JPC, Pompeo ACL, Bezerra CA. Argus T® versus advance® sling for postprostatectomy urinary incontinence: a randomized clinical trial. International braz j urol. 2016;42(3):531–9.CrossRefPubMedPubMedCentral
35.
Romano SV, Huebner W, Rocha FT, Vaz FP, Muller V, Nakamura F. A transobturator adjustable system for male incontinence: 30-month follow-up of a multicenter study. International braz j urol. 2014;40(6):781–9.CrossRefPubMed
36.
Hoda MR, Primus G, Fischereder K, Von Heyden B, Mohammed N, Schmid N, et al. Early results of a European multicentre experience with a new self-anchoring adjustable transobturator system for treatment of stress urinary incontinence in men. BJU Int. 2013;111(2):296–303. doi:10.​1111/​j.​1464-410X.​2012.​11482.​x.CrossRefPubMed
37.
Seweryn J, Bauer W, Ponholzer A, Schramek P. Initial experience and results with a new adjustable transobturator male system for the treatment of stress urinary incontinence. J Urol. 2012;187(3):956–61.CrossRefPubMed
38.
Friedl A, Mühlstädt S, Zachoval R, Giammò A, Kivaranovic D, Rom M et al. Long-term outcome of the adjustable transobturator male system (ATOMS): results of a European multicentre study. BJU international. 2016.
39.
Mühlstädt S, Friedl A, Mohammed N, Schumann A, Weigand K, Kawan F, et al. Five-year experience with the adjustable transobturator male system for the treatment of male stress urinary incontinence: a single-center evaluation. World J Urol. 2017;35(1):145–51.CrossRefPubMed
40.
Comiter CV, Nitti V, Elliot C, Rhee E. A new quadratic sling for male stress incontinence: retrograde leak point pressure as a measure of urethral resistance. J Urol. 2012;187(2):563–8.CrossRefPubMed
41.
Comiter CV, Rhee EY, Tu L-M, Herschorn S, Nitti VW. The virtue sling—a new quadratic sling for postprostatectomy incontinence—results of a multinational clinical trial. Urology. 2014;84(2):433–9.CrossRefPubMed
42.
• AN MC, Rivera ME, Elliott DS. Long-term follow-up of the virtue quadratic male sling. Urology. 2016;93:213–6. A prospective cohort study looking at the Advance vs Advance XP. Although the authors had longer term data, they did a 3-month review for comparison purposes. They found no significant difference at 3 months in objective or subjective parameters between the two slings. Interesting, they did find a statistically significant benefit in a subgroup analysis of obese (BMI 25-30) patients, thus they concluded that the new characteristics of the Advance XP sling may serve some benefit for larger patients CrossRef
43.
Cornu J-N, Da Costa JB, Henry N, Peyrat L, Beley S, Haab F. Comparative study of AdVance and AdVanceXP male slings in a tertiary reference center. Eur Urol. 2014;65(2):502–4.CrossRefPubMed
44.
Bauer RM, Kretschmer A, Stief CG, Füllhase C. AdVance and AdVance XP slings for the treatment of post-prostatectomy incontinence. World J Urol. 2015;33(1):145–50.CrossRefPubMed
45.
Bauer RM, Gozzi C, Klehr B, Kretschmer A, Grabbert M, Rehder P, et al. AdVanceXP male sling: 2-year results of a multicentre study. World J Urol. 2016;34(7):1025–30.CrossRefPubMed
46.
Bauer RM, Grabbert MT, Klehr B, Gebhartl P, Gozzi C, Homberg R et al. 36-month data for the AdVance XP® male sling: results of a prospective multicentre study. BJU international. 2016.
47.
Kretschmer A, Grabbert M, Sommer A, Stief CG, Bauer RM. Mid-term outcomes after AdVanceXP male sling implantation. BJU Int. 2016;118(3):458–63.CrossRefPubMed
48.
Van Bruwaene S, De Ridder D, Van der Aa F. The use of sling vs sphincter in post-prostatectomy urinary incontinence. BJU Int. 2015;116(3):330–42.CrossRefPubMed
49.
Torrey R, Rajeshuni N, Ruel N, Muldrew S, Chan K. Radiation history affects continence outcomes after advance transobturator sling placement in patients with post-prostatectomy incontinence. Urology. 2013;82(3):713–7.CrossRefPubMed
50.
Bauer RM, Soljanik I, Füllhase C, Karl A, Becker A, Stief CG, et al. Mid-term results for the retroluminar transobturator sling suspension for stress urinary incontinence after prostatectomy. BJU Int. 2011;108(1):94–8.CrossRefPubMed
51.
Castle EP, Andrews PE, Itano N, Novicki DE, Swanson SK, Ferrigni RG. The male sling for post-prostatectomy incontinence: mean followup of 18 months. J Urol. 2005;173(5):1657–60.CrossRefPubMed
52.
Bauer RM, Soljanik I, Füllhase C, Buchner A, May F, Stief CG, et al. Results of the AdVance transobturator male sling after radical prostatectomy and adjuvant radiotherapy. Urology. 2011;77(2):474–9.CrossRefPubMed
53.
Singh M, Bushman W, Clemens JQ. Do pad tests and voiding diaries affect patient willingness to participate in studies of incontinence treatment outcomes? J Urol. 2004;171(1):316–8.CrossRefPubMed
54.
Barnard J, Rij S, Westenberg AM. A Valsalva leak-point pressure of> 100 cmH2O is associated with greater success in AdVance™ sling placement for the treatment of post-prostatectomy urinary incontinence. BJU Int. 2014;114(S1):34–7.CrossRefPubMed
55.
Warner JN, Grimsby GM, Tyson MD, Wolter CE. Bladder capacity on preoperative urodynamics may impact outcomes on transobturator male slings. Neurourol Urodyn. 2012;31(7):1124–7.CrossRefPubMed
56.
Soljanik I, Bauer RM, Stief CG, Gozzi C, Becker AJ. Pelvic floor muscle function is an independent predictor of outcome after retrourethral transobturator male sling procedure. World J Urol. 2015;33(8):1143–9.CrossRefPubMed
57.
Martinez EJ, Zuckerman JM, Henderson K, Edwards B, McCammon K. Evaluation of salvage male transobturator sling placement following recurrent stress urinary incontinence after failed transobturator sling. Urology. 2015;85(2):478–82.CrossRefPubMed
Metadaten
Titel
The Male Transobturator Sling for Stress Incontinence After the Treatment of Prostate Cancer
verfasst von
James Mason
Bradley Erickson
Publikationsdatum
27.04.2017
Verlag
Springer US
Erschienen in
Current Bladder Dysfunction Reports / Ausgabe 2/2017
Print ISSN: 1931-7212
Elektronische ISSN: 1931-7220
DOI
https://doi.org/10.1007/s11884-017-0425-4

Weitere Artikel der Ausgabe 2/2017

Current Bladder Dysfunction Reports 2/2017 Zur Ausgabe

BPH-Related Voiding Dysfunction (R Lee, Section Editor)

Accurate Estimation of Prostate Size in the Evaluation of Nocturia

Cancer-Associated Voiding Dysfunction (A Peterson, Section Editor)

Urinary Diversion for Incontinence and Voiding Dysfunction in Cancer Survivors: a Critical Review of the Literature

Cancer-Associated Voiding Dysfunction (A Peterson, Section Editor)

The Artificial Urinary Sphincter: Evolution and Implementation of New Techniques in the Man with Stress Incontinence After Treatment for Prostate Cancer

Cancer-Associated Voiding Dysfunction (A Peterson, Section Editor)

Neuromodulation in the Treatment of Voiding Dysfunction and Fecal Incontinence in Male and Female Cancer Survivors

Cancer-Associated Voiding Dysfunction (A Peterson, Section Editor)

The Pharmacologic Management of Voiding Dysfunction, Stress Incontinence and the Overactive Bladder in Men and Women Who Have Had Prior Treatment for Pelvic Malignancies With Surgery or Radiation Therapy

Cancer-Associated Voiding Dysfunction (A Peterson, Section Editor)

Outlet Procedures in Female Cancer Survivors for the Treatment of Stress Incontinence: Differences in Indications, Technique, and Outcome for the Cancer Survivor

Neu im Fachgebiet Urologie

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise